Delivery Order SPE2DB24D2018-SPE2DB25FWWN0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-unit pack) on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract for pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,771.04 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, performing in Conshohocken, Pennsylvania, and scheduled for completion by October 14, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) under a firm fixed-price contract. The award was made on September 24, 2025, with an ultimate completion date of October 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total ceiling...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The award, made on September 29, 2025, with an ultimate completion date of October 21, 2025, was competitively awarded without set-aside designation under a firm fixed-price contract structure. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $4,156.56 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a $4,156.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit dose packaging). The contract is categorized as a non-set-aside competitive award with an ultimate completion date of October 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 28, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical products will be delivered...
- The Defense Logistics Agency awarded a competitive, firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. The contract ceiling value is $1,385.52, with an ultimate completion date of September 10, 2025. This delivery order represents a child contract executed under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWN0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count packaging) on September 2, 2025, with completion targeted for September 23, 2025. This firm fixed-price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in the federal medical procurement landscape through its extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for Orgovyx, a treatment within the company's broader oncology and specialty pharmaceutical offerings, reflects the contractor's ongoing capability to fulfill specialized federal medical supply requirements through established contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 9/2/25 |